The biological mechanism for this syndrome of TTS is still being investigated.
10692
在现阶段，与腺病毒载体疫苗有关的“特定平台”机制尚不确定，但不能被排除。
At this stage, a ‘platform specific’ mechanism related to the adenovirus-vectored vaccines is not certain but cannot be excluded.
10693
正在对血栓性血小板减少综合征病例进行的审查和相关研究应包括使用腺病毒载体平台的所有疫苗。
Ongoing review of TTS cases and related research should include all vaccines using adenoviral vector platforms.
10694
全球疫苗安全咨询委员会指出，在美国接种强生疫苗后，已对血栓性血小板减少综合征的发生情况展开调查。
The GACVS noted that an investigation has been initiated into the occurrence of TTS following the Johnson & Johnson vaccine administered in the United States.
Data from the UK suggest the risk is approximately four cases per million adults (1 case per 250 000) who receive the vaccine, while the rate is estimated to be approximately 1 per 100 000 in the European Union (EU).
Countries assessing the risk of TTS following COVID-19 vaccination should perform a benefit-risk analysis that takes into account local epidemiology (including incidence and mortality from COVID-19 disease), age groups targeted for vaccination and the availability of alternative vaccines.
10699
目前正在努力了解血栓性血小板减少综合征的风险因素。
Work is ongoing to understand risk factors for TTS.
10700
一些调查人员已经调查了血栓性血小板减少综合征的年龄分布情况 2 。
Some investigators have looked into rates of TTS by age 2 .